motega health
Developer of oral mucosal and targeted drug delivery technologies for human and animal applications. Offers formulation development across solid, semi-solid and liquid dosage forms, sustained- and controlled-release systems, transdermal and long-acting inserts, sterile injectable capability, nutraceutical and specialty food product development, and licensing/commercialization of ready-to-license assets.
Industries
Nr. of Employees
small (1-50)
motega health
Products
Oral testosterone product
An orally administered testosterone formulation designed for systemic absorption via the oral mucosa without increased hepatotoxicity risk.
Nicotine replacement delivery technology
A semi-liquid oral mucosal nicotine delivery format intended to provide rapid onset and extended therapeutic effect while avoiding side-effects of some other NRT formats.
Vaginal mucoadhesive formulation
A vaginal formulation engineered with pseudoplastic rheology to retain in the vagina for 12–24 hours and function across pH and different APIs.
Nicotine Replacement Product
A nicotine delivery technology for licensing that enhances therapeutic function and avoids side effects of current oral nicotine replacement therapy products, delivered as a semi-liquid dosage form applied buccally to gums or inner cheek via spray device.
Oral Testosterone
An oral testosterone product based on Motega’s patented oral drug delivery system allowing systemic absorption of natural testosterone without hepatotoxicity, suitable for men with low T and postmenopausal or hysterectomized women.
Women’s Health
A vaginal formulation with pseudoplastic rheology ensuring 12-24 hrs retention in the vagina, effective across pH, API, and contraceptive spaces, available for licensing.
Oral testosterone product
An orally administered testosterone formulation designed for systemic absorption via the oral mucosa without increased hepatotoxicity risk.
Nicotine replacement delivery technology
A semi-liquid oral mucosal nicotine delivery format intended to provide rapid onset and extended therapeutic effect while avoiding side-effects of some other NRT formats.
Vaginal mucoadhesive formulation
A vaginal formulation engineered with pseudoplastic rheology to retain in the vagina for 12–24 hours and function across pH and different APIs.
Nicotine Replacement Product
A nicotine delivery technology for licensing that enhances therapeutic function and avoids side effects of current oral nicotine replacement therapy products, delivered as a semi-liquid dosage form applied buccally to gums or inner cheek via spray device.
Oral Testosterone
An oral testosterone product based on Motega’s patented oral drug delivery system allowing systemic absorption of natural testosterone without hepatotoxicity, suitable for men with low T and postmenopausal or hysterectomized women.
Women’s Health
A vaginal formulation with pseudoplastic rheology ensuring 12-24 hrs retention in the vagina, effective across pH, API, and contraceptive spaces, available for licensing.
Services
Custom development of solid, semi-solid, semi-liquid and liquid dosage forms for human and animal use; includes taste masking, mucoadhesive systems and controlled-release designs.
Support for sterile product development and manufacturing setup, including sustained-release injectables and aseptic processes.
Licensing-ready product assets and support for patenting and commercial strategy to bring technologies to market.
Custom development of solid, semi-solid, semi-liquid and liquid dosage forms for human and animal use; includes taste masking, mucoadhesive systems and controlled-release designs.
Support for sterile product development and manufacturing setup, including sustained-release injectables and aseptic processes.
Licensing-ready product assets and support for patenting and commercial strategy to bring technologies to market.
Expertise Areas
- Oral mucosal drug delivery
- Sustained- and controlled-release formulation
- Formulation development for human and veterinary products
- Sterile injectable development and manufacturing
Key Technologies
- Oral mucosal absorption
- Buccal spray and gum-applied delivery
- Semi-solid and semi-liquid dosage platforms
- Mucoadhesive formulations with pseudoplastic rheology
News & Updates
Interview article linked from company media page.
Profile article about the company's technology focus linked from media page.
Press/announcement linked from company media page.
Interview article linked from company media page.
Profile article about the company's technology focus linked from media page.
Press/announcement linked from company media page.